Sofosbuvir(1064684-44-1)
- Name: Sofosbuvir
- Synonyms:PSI 7977; L-Alanine, N-[[p(S),2'R]-2'-deoxy-2'-fluoro-2'-methyl-p-phenyl-5'-uridylyl]-, 1-methylethyl ester; Psi-7977; (S)-isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate; sofosvuvir form6; sovaldi API; sofosbuvir form6; GS-7977; Sopropyl-(2S)-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl]-4-fluoro-3-hydroxy-4-methy-ltetrahydrofuran-2-yl]methoxy-phenoxy-phosphoryl]amino]propanoate; Sofasbuvir
- Molecular Formula:C22H29FN3O9P
- Molecular Weight:529.459
- CAS Registry Number:1064684-44-1
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 414910-27-3/casopitant
- 1022957-12-5/Bicyclo[2.2.1]hept-5-ene-2-carboxamide, 3-[[5-chloro-2-[(1-ethyl-2,3,4,5-tetrahydro-6-methoxy-2-oxo-1H-1-benzazepin-7-yl)amino]-4-pyrimidinyl]amino]-, (1S,2S,3R,4R)-
- 1076225-27-8/4-((1R,2R)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile
- 166095-95-0/2H-1-Benzopyran-6-carbonitrile, 4-[(4-chlorophenyl)(1H-imidazol-2-ylmethyl)amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-, monohydrochloride, (3R,4S)- (9CI)
- 163521-08-2/5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide hydrochloride
- 940907-93-7/Benzonitrile, 2-[[2-[(3R)-3-amino-1-piperidinyl]-4-oxo-3(4H)-quinazolinyl]methyl]-
- 241479-67-4/Isavuconazole
- 135017-30-0/Propanedinitrile, 2-[1-[2-[[[5-(1-piperidinylmethyl)-2-furanyl]methyl]amino]ethyl]-2-imidazolidinylidene]-
- 862541-45-5/PF 610355
- 652990-07-3/Milveterol
- 804518-03-4/Milveterol hydrochloride
- 503068-34-6/Vilanterol
- 623152-17-0/BMS 582949
- 1064684-44-1/Sofosbuvir
- 260270-37-9/6,9-Imino-5H-cyclohepta[c]pyridine, 6,7,8,9-tetrahydro-, (6R,9S)-
- 934995-87-6/MK-0952
- 934995-88-7/Cyclopropanecarboxylic acid, 2-[3'-[3-[(cyclopropylamino)carbonyl]-4-oxo-1,8-naphthyridin-1(4H)-yl]-3-fluoro[1,1'-biphenyl]-4-yl]-, sodium salt (1:1), (1R,2R)-
- 346629-30-9/6-(1-METHANESULFONYL-1-METHYL-ETHYL)-8-(3-[(E)-2-(4-METHANESULFONYL-PHENYL)-2-(3-METHYL-[1,2,4]OXADIAZOL-5-YL)-VINYL]-PHENYL)-QUINOLINE
- 778625-65-3/MK-0489
- 870615-40-0/6H-[1,2,4]Triazolo[4,3-a][1,5]benzodiazepine-6-acetamide, 4,5-dihydro-4-(1H-indol-3-ylmethyl)-N-(1-methylethyl)-5-oxo-1-phenyl-N-(phenylmethyl)-, (-)-
- 870615-43-3/6H-[1,2,4]Triazolo[4,3-a][1,5]benzodiazepine-6-acetamide, 4,5-dihydro-4-(1H-indol-3-ylmethyl)-N-(1-methylethyl)-5-oxo-1-phenyl-N-(phenylmethyl)-
- 305366-98-7/GI 181771
- 221671-61-0/SR 146131
- 897367-47-4/DP-802
- 897371-87-8/DP-1376
- 331758-35-1/T-226296
- 427878-02-2/Pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide, N-ethyl-4-[[5-[(methoxyamino)carbonyl]-2-methylphenyl]amino]-5-methyl-
- 887701-48-6/1H-Pyrazole-5-heptanoic acid, 1-(4-fluorophenyl)-b,d-dihydroxy-4-(1-methylethyl)-3-[[[(4-methylphenyl)methyl]amino]carbonyl]-, (bR,dR)-
- 724444-40-0/Ethanediamide, N1-[(10S)-2-[[[(4-fluorophenyl)methyl]amino]carbonyl]-4,6,7,8,9,10-hexahydro-3-hydroxy-4-oxopyrimido[1,2-a]azepin-10-yl]-N1,N2,N2-trimethyl-
- 226878-01-9/NPS 2390